Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy

BACKGROUND: to evaluate the role of a risk stratification system in intermediate-risk prostate cancer (PCa) treated with hypofractionated radiotherapy (HyRT). METHODS: 131 patients affected by intermediate-risk PCa were treated with HyRT at the total dose of 54,75 Gy in 15 fraction plus 9 months of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Oncol
Main Authors: Bracci, Stefano, Osti, Mattia F., Agolli, Linda, Bertaccini, Luca, De Sanctis, Vitaliana, Valeriani, Maurizio
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4898326/
https://ncbi.nlm.nih.gov/pubmed/27276878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-016-0656-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados